GLP-1 & Metabolic Psychiatry at 39th ECNP Congress
1 session on glp-1 & metabolic psychiatry · October 10–13, 2026, Munich, Germany. Compare glp-1 & metabolic psychiatry at other meetings →
Sunday, October 11
Session
RS – Regulatory Spotlight Session – Metabolic risks of psychiatric medications: improving clinical safety through regulatory, industry, and academic insights
Margaret Hahn · Vikas Mohan Sharma · Katarina Vucic
Academic, industry, and regulator perspectives on managing metabolic risks of psychotropic medications.
Other topics at this meeting
Neuroscience & Mechanisms 23Drug Pipeline & Clinical Trials 8Digital Psychiatry & AI 7Pharmacogenomics & Precision Psychiatry 7Inflammation & Immunopsychiatry 6Schizophrenia & Psychosis 6Child & Adolescent 5Depression 5Autism & Neurodevelopmental Disorders 4Neuromodulation (ECT, TMS) 4OCD & Related Disorders 4ADHD 3